[go: up one dir, main page]

DK0469125T3 - Substituerede 1-(alkoxyiminoalkyl)imidazolderivater - Google Patents

Substituerede 1-(alkoxyiminoalkyl)imidazolderivater

Info

Publication number
DK0469125T3
DK0469125T3 DK91904730.8T DK91904730T DK0469125T3 DK 0469125 T3 DK0469125 T3 DK 0469125T3 DK 91904730 T DK91904730 T DK 91904730T DK 0469125 T3 DK0469125 T3 DK 0469125T3
Authority
DK
Denmark
Prior art keywords
alkyl
optionally substituted
hydrogen
pct
cycloalkyl
Prior art date
Application number
DK91904730.8T
Other languages
Danish (da)
English (en)
Inventor
Paolo Cozzi
Patricia Salvati
Corrado Ferti
Maria Menichincheri
Arsenia Rossi
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909004347A external-priority patent/GB9004347D0/en
Priority claimed from GB909027551A external-priority patent/GB9027551D0/en
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Application granted granted Critical
Publication of DK0469125T3 publication Critical patent/DK0469125T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Luminescent Compositions (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Epoxy Resins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DK91904730.8T 1990-02-27 1991-02-26 Substituerede 1-(alkoxyiminoalkyl)imidazolderivater DK0469125T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909004347A GB9004347D0 (en) 1990-02-27 1990-02-27 Substituted 1-(alkoxy-iminoalkyl)-imidazole derivatives
GB909027551A GB9027551D0 (en) 1990-12-19 1990-12-19 Carboxy derivatives of substituted 1-(alkoxy-iminoalkyl)imidazole

Publications (1)

Publication Number Publication Date
DK0469125T3 true DK0469125T3 (da) 1995-03-27

Family

ID=26296723

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91904730.8T DK0469125T3 (da) 1990-02-27 1991-02-26 Substituerede 1-(alkoxyiminoalkyl)imidazolderivater

Country Status (19)

Country Link
US (1) US5280033A (fr)
EP (1) EP0469125B1 (fr)
JP (1) JPH04505464A (fr)
KR (1) KR920701168A (fr)
AT (1) ATE117995T1 (fr)
AU (1) AU644632B2 (fr)
CA (1) CA2053256A1 (fr)
DE (1) DE69107137T2 (fr)
DK (1) DK0469125T3 (fr)
ES (1) ES2074263T3 (fr)
FI (1) FI915056A0 (fr)
GR (1) GR3015820T3 (fr)
HU (1) HU209471B (fr)
IE (1) IE67286B1 (fr)
IL (1) IL97144A (fr)
MY (1) MY105343A (fr)
NZ (1) NZ237168A (fr)
PT (1) PT96895A (fr)
WO (1) WO1991013062A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116470D0 (en) * 1991-07-30 1991-09-11 Erba Carlo Spa 2-(imidazol-1-yl)-benzylethylidene-aminoxyalkanoic acid derivatives
GB9302599D0 (en) * 1993-02-10 1993-03-24 Erba Carlo Spa 2-(imadazol-l-yl)-heteroaryl-propylidene-aminoxyalkanoic acid derivatives
GB9315058D0 (en) * 1993-07-20 1993-09-01 Erba Carlo Spa 2-(imidazol-1-yl)benzylethylidene-aminooxylkyl-hydroxamic acid derivatives
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
WO1999045905A2 (fr) * 1998-03-13 1999-09-16 Pozen Inc. Prophylaxie et traitement de la migraine par les inhibiteurs de thromboxane synthetase et/ou les antagonistes de recepteur de thromboxane
US20070167490A1 (en) * 2003-03-13 2007-07-19 Ono Pharmaceutical Co Ltd Imino ether derivative compounds and drugs containing the compounds as the active ingredient
CN112574176B (zh) * 2019-09-27 2024-03-15 隆泰申医药科技(南京)有限公司 一种杂芳基类化合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4085209A (en) * 1975-02-05 1978-04-18 Rohm And Haas Company Preparation and safening effect of 1-substituted imidazole metal salt complexes
US4352804A (en) * 1978-07-25 1982-10-05 Acf Chemiefarma Nv Oxime ethers, their preparation and pharmaceutical compositions containing them
DE2944446A1 (de) * 1979-11-03 1981-06-11 Bayer Ag, 5090 Leverkusen Trisubstituierte benzyl-oximether, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide
EP0034249B1 (fr) * 1980-02-08 1984-10-24 Gruppo Lepetit S.P.A. Dérivés du naphtimidazole et du naphtoxazole, leur préparation et leur utilisation dans des médicaments
DE3116888A1 (de) * 1981-04-28 1982-11-11 Bayer Ag, 5090 Leverkusen "azolylpropyl-oximino-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und pflanzenwachstumsregulatoren"
EP0132771A2 (fr) * 1983-07-22 1985-02-13 Hoechst Aktiengesellschaft Dérivés de 1,2-diaryl-3-azolyl-propane, leur préparation et utilisation dans le traitement des plantes
DE3334220A1 (de) * 1983-09-22 1985-04-11 Bayer Ag, 5090 Leverkusen 1-azolyl-substituierte oximether
DE3413365A1 (de) * 1984-04-09 1985-12-19 Merz + Co GmbH & Co, 6000 Frankfurt Substituierte phenylethylderivate, verfahren zu ihrer herstellung und pharmazeutische mittel
DE3545085A1 (de) * 1985-12-19 1987-07-02 Bayer Ag Substituierte cyclopropyl-oximether

Also Published As

Publication number Publication date
DE69107137D1 (de) 1995-03-16
FI915056A7 (fi) 1991-10-25
WO1991013062A2 (fr) 1991-09-05
WO1991013062A3 (fr) 1991-10-17
IL97144A0 (en) 1992-05-25
CA2053256A1 (fr) 1991-08-28
IE67286B1 (en) 1996-03-20
DE69107137T2 (de) 1995-06-01
ATE117995T1 (de) 1995-02-15
IL97144A (en) 1994-11-28
IE910647A1 (en) 1991-08-28
HU209471B (en) 1994-06-28
PT96895A (pt) 1991-10-31
EP0469125B1 (fr) 1995-02-01
NZ237168A (en) 1992-07-28
US5280033A (en) 1994-01-18
AU7304391A (en) 1991-09-18
KR920701168A (ko) 1992-08-11
ES2074263T3 (es) 1995-09-01
HU913625D0 (en) 1992-03-30
AU644632B2 (en) 1993-12-16
MY105343A (en) 1994-09-30
EP0469125A1 (fr) 1992-02-05
JPH04505464A (ja) 1992-09-24
FI915056A0 (fi) 1991-10-25
HUT59910A (en) 1992-07-28
GR3015820T3 (en) 1995-07-31

Similar Documents

Publication Publication Date Title
NO20044592L (no) Aryl keton pyrrolo-triazinforbindelser nyttige som kinase inhibitorer
DK0560177T3 (da) Imidazol-derivater med biphenylsulfonylurinstof- eller biphenylsulfonylurethan-sidekæde, fremgangsmåder til deres fremstilling og deres anvendelse.
ES2162668T3 (es) Derivados de bifenilo o de fenil-piridina sustituidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
ATE72436T1 (de) 2-(methyl(4-piperidinyl)>-1,2,3,4-tetrahydro-9h pyrido(3,4-b>indolderivate, ihre herstellung und therapeutische verwendung.
DK0677046T3 (da) Piperazinderivater som 5-HT-antagonister.
DK170188D0 (da) Carbinolderivater
DE60107435D1 (de) 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission
DK0804437T3 (da) [a]-Annelerede pyrrolderivater og deres anvendelse i farmacien
CO5170512A1 (es) Derivados de tetrahidroquinolin piperidina
DE69433984D1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
DK0821682T3 (da) Benzimidazolforbindelser og deres anvendelse som modulatorer af gaba-a-receptorkomplekset
DK0469125T3 (da) Substituerede 1-(alkoxyiminoalkyl)imidazolderivater
EA200501703A1 (ru) Применение производных азетидинкарбоксамида в терапии
NO20022232L (no) Imidazolforbindelser for anvendelse som inhibitorer for fosfodiesterase VII
DE69419917D1 (de) Indazolderivate
ATE318810T1 (de) 3-oxadiazol-5-yl-1-aminoalkyl-1h-indolderivate
MY131096A (en) N-imidazolyl derivatives of substituted indole.
GB9300195D0 (en) Piperazine derivatives
DE69525633D1 (de) Chinoxalinderivate und ihre therapeutische verwendbarkeit
DK0689534T3 (da) Amidderivater som 5-HT1A-ligander
DK0683777T3 (da) Oxindol-1-N-(alkoxycarbonyl)carboxamider og -1-(N-carboxamido)carboxamider som antiinflammatoriske midler
TR200200614T2 (tr) Vitronektin reseptörü antagonistleri
NO20003138L (no) Ny anvendelse av lokalanestetika mot vaskulære hodepiner
DE69227461D1 (de) Anthelmintische benzimidazole